Cryoport, Inc. (CYRX) stock
CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3022% above fair value
$19.74−0.06 (-0.30%)
Close on Nov 17, 2026Market cap $999.81MP/E –Yield –
Cryoport price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Cryoport's price to sales ratio was 5.6× on Nov 11, 2026, against 2.8× a year earlier. Over the last 5 years it ranged from 1.6× to 12.7×, with a median of 3.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.6× | +2.8 |
| 2025 | Dec 31, 2025 | 2.8× | +0.6 |
| 2024 | Dec 31, 2024 | 2.2× | −1.0 |
| 2023 | Dec 29, 2023 | 3.2× | −0.4 |
| 2022 | Dec 30, 2022 | 3.6× | −9.1 |
| 2021 | Dec 31, 2021 | 12.7× | −30.5 |
| 2020 | Dec 31, 2020 | 43.2× | +23.8 |
| 2019 | Dec 31, 2019 | 19.4× | −35.4 |
| 2018 | Dec 31, 2018 | 54.8× | +36.9 |
| 2017 | Dec 29, 2017 | 17.9× | +11.1 |
| 2016 | Dec 30, 2016 | 6.7× | +4.1 |
| 2015 | Dec 31, 2015 | 2.7× | −5.2 |
| 2014 | Dec 31, 2014 | 7.9× | −2.8 |
| 2013 | Dec 31, 2013 | 10.7× | −23.1 |
| 2012 | Dec 31, 2012 | 33.7× | −62.0 |
| 2011 | Dec 30, 2011 | 95.7× | – |
See a number that looks wrong?